IP Library › Assignment 057116/0012
Patent Assignment
Reel/Frame 057116/0012

Assignment of Assignor's Interest

Recorded: 2021-08-06 Pages: 4
Assignors
ARLIN, JEAN-BAPTISTE
Executed: 2018-04-30
FERNANDEZ CASARES, ANA
Executed: 2018-04-24
Assignee
CRYSTALLICS B.V.
MEIBERGDREEF 31, AMSTERDAM, 1105 AZ, NETHERLANDS
Covered Property (1)
Solid Forms and Combination Compositions Comprising a Beta-Lactamase Inhibitor and Uses Thereof
Application: 17/353,377 →
Publication: US 2022/0002322
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 6, 2021
From: CRYSTALLICS B.V.
To: VENATORX PHARMACEUTICALS, INC.
Reel/Frame 057110/0850 →
Assignment of Assignor's Interest Aug 6, 2021
From: BRENNER, GERALD
To: VENATORX PHARMACEUTICALS, INC.
Reel/Frame 057116/0009 →
Assignment of Assignor's Interest Aug 6, 2021
From: BURNS, CHRISTOPHER J.; PEVEAR, DANIEL C.; XERRI, LUIGI; HENKEL, TIMOTHY
To: VENATORX PHARMACEUTICALS, INC.
Reel/Frame 057116/0016 →
License Dec 20, 2024
From: VENATORX PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 069744/0492 →